Register entry
Axsome Therapeutics, Inc.
- Registered sites
- 0
- Drug products
- 7
- Live patents
- 298
- Countries
- 0
- Base
- Unknown
Sites
Facilities
0No registered facilities
This company holds drug listings or approvals but operates no registered establishment of its own, which is normal for an NDA holder that outsources manufacturing.
Exclusivity
Patents
298Unexpired Orange Book patents where this company is the application holder.
| Product | Active ingredient | Expiry |
|---|---|---|
| AUVELITY | BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE | Jul 2032 |
| AUVELITY | BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE | Nov 2034 |
| AUVELITY | BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE | Jan 2040 |
| AUVELITY | BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE | Jun 2040 |
| AUVELITY | BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE | Dec 2041 |
| AUVELITY | BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE | Jan 2043 |
| AUVELITY | BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE | Jan 2043 |
| AUVELITY | BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE | Feb 2043 |
| AUVELITY | BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE | Feb 2043 |
| AUVELITY | BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE | Mar 2043 |
| AUVELITY | BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE | Apr 2043 |
| AUVELITY | BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE | Nov 2043 |
| SYMBRAVO | MELOXICAM; RIZATRIPTAN BENZOATE | Apr 2036 |
| SYMBRAVO | MELOXICAM; RIZATRIPTAN BENZOATE | May 2038 |
| SYMBRAVO | MELOXICAM; RIZATRIPTAN BENZOATE | May 2040 |
| SYMBRAVO | MELOXICAM; RIZATRIPTAN BENZOATE | Dec 2041 |
| SYMBRAVO | MELOXICAM; RIZATRIPTAN BENZOATE | Jan 2043 |
| SYMBRAVO | MELOXICAM; RIZATRIPTAN BENZOATE | Mar 2045 |
Catalogue
Marketed products
7Showing 7 of 7.
| Brand | Generic name | Form | Category |
|---|---|---|---|
| AUVELITY | dextromethorphan hydrobromide, bupropion hydrochloride | TABLET, MULTILAYER, EXTENDED RELEASE | NDA |
| AUVELITY | dextromethorphan hydrobromide, bupropion hydrochloride | TABLET, MULTILAYER, EXTENDED RELEASE | NDA |
| AUVELITY | dextromethorphan hydrobromide, bupropion hydrochloride | KIT | NDA |
| AUVELITY | dextromethorphan hydrobromide, bupropion hydrochloride | KIT | NDA |
| SUNOSI | solriamfetol | TABLET, FILM COATED | NDA |
| SUNOSI | solriamfetol | TABLET, FILM COATED | NDA |
| SYMBRAVO | meloxicam, rizatriptan | TABLET | NDA |
Provenance
Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.